Myalgic Encephalomyelitis/Chronic Fatigue Syndrome And Post COVID-ME Patient Perceptions On Activity Management Strategies
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 23-003111
About this study
The purpose of this study is to evaluate the experiences of patients with ME/CFS and Long COVID as related to paced activity via an online, narrative-based questionnaire in order to further elucidate its role in management of this debilitating condition.
Update 10/8/24: In the next phase of this study, the results of the aforementioned questionnaire are applied to developing materials that will be used to update our Fibromyalgia & ME/Chronic Fatigue Sydndrome treatment program. A pre- and post- cohort of 30 patients each will be evaluated to assess differences in outcomes based on these changes.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Age 18+, prior diagnosis of ME/CFS / Long COVID Syndrome with ME/CFS.
- Adults 18+ with diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome including Long COVID with ME/CFS.
Exclusion Criteria:
- Age <18, no prior diagnosis of ME/CFS / Long COVID Syndrome with ME/CFS.
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Eligibility last updated 9/25/23. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Stephanie Grach, M.D., M.S. |
Contact us for the latest status |
|
More information
Publications
Publications are currently not available